APA (7th ed.) Citation

Yuan, M., Song, L., Wang, Z., Zhang, Z., Shi, M., He, J., . . . Cai, J. (2025). Long-term outcomes of mesenchymal stem cell therapy in severe COVID-19 patients: 3-year follow-up of a randomized, double-blind, placebo-controlled trial. Stem Cell Research & Therapy, 16(1), 1. https://doi.org/10.1186/s13287-025-04148-1

Chicago Style (17th ed.) Citation

Yuan, Meng-Qi, et al. "Long-term Outcomes of Mesenchymal Stem Cell Therapy in Severe COVID-19 Patients: 3-year Follow-up of a Randomized, Double-blind, Placebo-controlled Trial." Stem Cell Research & Therapy 16, no. 1 (2025): 1. https://doi.org/10.1186/s13287-025-04148-1.

MLA (9th ed.) Citation

Yuan, Meng-Qi, et al. "Long-term Outcomes of Mesenchymal Stem Cell Therapy in Severe COVID-19 Patients: 3-year Follow-up of a Randomized, Double-blind, Placebo-controlled Trial." Stem Cell Research & Therapy, vol. 16, no. 1, 2025, p. 1, https://doi.org/10.1186/s13287-025-04148-1.